# Treatment of Corneal Abrasions With Topical Tetracaine

> **NCT02771392** · PHASE2,PHASE3 · UNKNOWN · sponsor: **New York Presbyterian Brooklyn Methodist Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Corneal Abrasion

## Interventions

- **DRUG:** Ophthalmic Tetracaine
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT02771392
- **Lead sponsor:** New York Presbyterian Brooklyn Methodist Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-06
- **Primary completion:** 2018-06
- **Final completion:** 2018-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02771392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02771392, "Treatment of Corneal Abrasions With Topical Tetracaine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02771392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*